Soleno Therapeutics Inc (6XC.BE)
Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
At close: 08:08PM CEST
| Previous Close | 39.08 |
| Open | 38.08 |
| Bid | 37.80 x N/A |
| Ask | 38.98 x N/A |
| Day's Range | 37.42 - 38.54 |
| 52 Week Range | 3.48 - 49.00 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
While institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the most
Key Insights Significant control over Soleno Therapeutics by private equity firms implies that the general public has...
- GuruFocus.com
CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
- GuruFocus.com
Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
© 2024 Yahoo. All rights reserved.